Douglas Mann, MD: Challenging The Prevailing Dogma


Experts at the European Society of Cardiology Congress 2016 (ESC) expressed varied opinions on the DANISH trial. Researchers presented that implantable cardioverter-defibrillators (ICDs) do not work for all heart patients.

Douglas Mann, MD expressed his opinion regarding the results of the DANISH trial that were presented today at the European Society of Cardiology Congress 2016 (ESC). "Technically the trial is neutral or people want to say negative, but from a clinical stand point, the device does work - just not in everybody," Mann remarked. According to Mann, in patients older than 70 years, physicians might be more conservative about recommending ICDs; there was also a 5% rate of complications in placing ICDs, which is relatively high in this age group.

Related Videos
Timothy Wilt, MD, MPH | Credit: ACP
HCPLive Five at ACC 2024 | Image Credit: HCPLive
Ankeet Bhatt, MD, MBA | Credit:
Ankeet Bhatt, MD, MBA | Credit:
Sara Saberi, MD | Credit: University of Michigan
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
Albert Foa, MD, PhD | Credit: HCPLive
Veraprapas Kittipibul, MD | Credit:
© 2024 MJH Life Sciences

All rights reserved.